Dr. Lal PathLabs Limited

NSEI:LALPATHLAB Stock Report

Market Cap: ₹253.4b

Dr. Lal PathLabs Management

Management criteria checks 2/4

Dr. Lal PathLabs' CEO is Shankha Banerjee, appointed in May 2024, has a tenure of less than a year. directly owns 0.028% of the company’s shares, worth ₹71.51M. The average tenure of the management team and the board of directors is 4.6 years and 5.6 years respectively.

Key information

Shankha Banerjee

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.03%
Management average tenure4.6yrs
Board average tenure5.6yrs

Recent management updates

Recent updates

Analysts Are Updating Their Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Estimates After Its Second-Quarter Results

Oct 26
Analysts Are Updating Their Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Estimates After Its Second-Quarter Results

Capital Investment Trends At Dr. Lal PathLabs (NSE:LALPATHLAB) Look Strong

Oct 24
Capital Investment Trends At Dr. Lal PathLabs (NSE:LALPATHLAB) Look Strong

Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Share Price Could Signal Some Risk

Oct 06
Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Share Price Could Signal Some Risk

These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

Jul 28
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

We Think Dr. Lal PathLabs' (NSE:LALPATHLAB) Profit Is Only A Baseline For What They Can Achieve

May 21
We Think Dr. Lal PathLabs' (NSE:LALPATHLAB) Profit Is Only A Baseline For What They Can Achieve

What Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) P/E Is Not Telling You

May 01
What Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) P/E Is Not Telling You

Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Apr 13
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

Mar 06
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely

Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next

Feb 04
Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next

Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price

Dec 28
Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price

Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Nov 17
Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around

Oct 12
Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around

Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly

Jul 07
Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly

Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Jun 10
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital

Feb 13
Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital

Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Dec 29
Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends

Sep 21
Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends

These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well

Sep 01
These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well

Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00

Jul 31
Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00

Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Jun 23
Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital

Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?

Jun 11
Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?

CEO

Shankha Banerjee

less than a year

Tenure

Mr. Shankha Banerjee serves as Chief Executive Officer of Group & Associates Companies at Dr. Lal PathLabs Limited. He served as Chief Operating Officer at Dr. Lal PathLabs Limited since 2020. He had been...


Leadership Team

NamePositionTenureCompensationOwnership
Arvind Lal
Executive Chairman29.8yrs₹30.14m32.93%
₹ 83.4b
Om Manchanda
MD & Director4.6yrs₹46.45m1.06%
₹ 2.7b
Vandana Lal
Executive Directorno data₹24.18m19.3%
₹ 48.9b
Shankha Banerjee
Chief Executive Officerless than a yearno data0.028%
₹ 71.5m
Ved Goel
Group CFO & CEO of International Business6.3yrs₹7.30m0.014%
₹ 36.7m
Jai Meena
Chief Operating Officer2.6yrsno datano data
Munender Soperna
Chief Information & Digital Officer10.4yrsno data0.025%
₹ 63.6m
Vinay Gujral
Company Secretary & Compliance Officer1.6yrsno data0%
₹ 0
Manoj Garg
Group Chief Human Resources Officer10.1yrsno data0.033%
₹ 82.7m

4.6yrs

Average Tenure

63.5yo

Average Age

Experienced Management: LALPATHLAB's management team is considered experienced (4.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Arvind Lal
Executive Chairman29.8yrs₹30.14m32.93%
₹ 83.4b
Om Manchanda
MD & Director13.8yrs₹46.45m1.06%
₹ 2.7b
Vandana Lal
Executive Director29.8yrs₹24.18m19.3%
₹ 48.9b
Arun Duggal
Lead Independent Director1.8yrs₹3.85mno data
Rajit Mehta
Independent Director1.3yrs₹1.56mno data
Rahul Sharma
Non Executive Director19.3yrs₹2.65m0.030%
₹ 76.0m
Rohit Bhasin
Independent Non-Executive Director2yrs₹2.60mno data
Somya Satsangi
Independent Director5.8yrs₹2.70mno data
Archana Erdmann
Non-Executive Director5.5yrs₹2.25m1.85%
₹ 4.7b
Gurinder Singh Kalra
Independent Director1.3yrs₹1.56mno data

5.6yrs

Average Tenure

63yo

Average Age

Experienced Board: LALPATHLAB's board of directors are considered experienced (5.6 years average tenure).